de-la-Puente-Ovejero, L., Fernández-Rodríguez, A., Francoz, S., Aizpurua, G., Lomba-Riego, L., Drosten, M., Guerra, C., Musteanu, M., Barbacid, M., García-Alonso, S. (2026). RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1. PLoS ONE. https://doi.org/10.1371/journal.pone.0341778